Boehringer Ingelheim Announces Strong 2012 Performance in China
CHINA - Boehringer Ingelheim has reported on its performance in the Chinese market in the business year 2012. With sales of €358 million (RMB2,904 million) marking growth of 32 per cent last year, the firm will accelerate its strategic business development in China, a market of significant importance to the company.
26 April 2013
2 minute read
